SAN FRANCISCO, February 17, 2021 / PRNewswire / – The size of the data analysis series is the next generation series expect to arrive USD 1.72 billion ro 2028 recording a CAGR of 15.02%, according to a new report by Grand View Research, Inc. Key drivers contributing to the expansion of the market include the adoption of series platforms for clinical diagnosis due to a significant reduction in installation cost. Genomic and proteomic data are also expected to easily create profitable growth opportunities in this market during the forecast period.
Key recommendations from the report:
- Services took control of the share of output in 2020 and will continue to grow the key position at the fastest CAGR in the forecast period
- While NGS is advantageous in terms of affordability and speed, many research organizations cannot accept it due to the lack of sufficient computer infrastructure and skilled professionals to analyze the information generated.
- Therefore, institutions that do not have provision for data interpretation, analysis and management will accept platforms & services offered by other companies in the market.
- Tertiary analysis took up a large part of the revenue generated by the workflow sector as it describes the most complex and important phase of the Next Generation Sequence, which directly related to the interpretation of results
- In-house mode took control of the market in 2020 and is expected to maintain dominance in the forecast period
- However, the external mode is expected to record the fastest CAGR from 2021 to 2028 due to the time and cost benefits associated with this method and the presence of key players offering analytics services. data
- The short readout piece led the global market in 2020 due to the widespread adoption of these methods as they are inexpensive and can work with DNA fragmentation along with several available tools and algorithms.
- The end-use segment of academic research generated the largest revenue in 2020; however, clinical study is estimated to be the fastest growing piece from 2021 to 2028
- North America gained control of the global market in 2020 as a result of the launch of major genome projects and the rise in demand for personalized medicine
Read ToC’s 189-page 189-page research report on “Next-generation Sequencing Data Analysis Report, segment analysis report & trends by product, by workflow, by method, by reading length, by end-use, by area, and cookie projections, 2021 – 2028 “by: https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-data-analysis-market
In addition, a reduction in the cost of sequencing is expected to lead to the adoption of next-generation series (NGS), which, in turn, is likely to stimulate market growth. Access to tools, such as the Agilent HaloPlex capture system and the Methyl-Seq Targeted platform from EpiGentek Group Inc., has helped validate DNA methylation profiles in individual genomes. An increase in bisulfite-methylation uptake for targeted strains and NNA-targeted methylation data analysis methods is expected to drive market growth.
EpigenDx, CD Genomics, Novogene Co., Ltd., and Epigentek Group, Inc. the major players offering a series of methylation and targeted bisulfite order data analysis services. The launch of new products will further increase market revenue generation. Key market participants have undertaken a number of strategic initiatives to strengthen the market position. For example, in January 2021, Transnetyx, Inc. collaborated. with One Codex to provide end-to-end analytics and microorganisms services. This is expected to provide affordable order analysis services for researchers.
Grand View Research has segmented the next generation global data analytics market on a product basis, workflow, method, reading lengths, end use and area:
- Next-generation data analysis output forecast (revenue, USD million, 2017 – 2028)
- Services
- NGS Commercial Software
- OS / UI platform
- Analysis software
- Alignment tools & software
- DNA alignment Seq
- RNA Alignment Seq
- Alignment of Seq protein
- QC / Pre-processing equipment
- Others
- Next generation data analysis workflow analysis (revenue, USD million, 2017 – 2028)
- Primary school
- secondary school
- Read Mapping
- Different alignment & variable call
- Tertiary
- Variable change
- Special request
- Targeted Classification / Gene Panel
- Exome Sequence
- RNA sequence
- Complete Genome Sequence
- ChIP-classification
- Others
- Next-Generation Sequencing Data Analysis Method Preview (Revenue, USD Million, 2017 – 2028)
- Next generation order data analysis Read Length Forecast (Revenue, USD Million, 2017 – 2028)
- Short reading
- Long read
- Very Long read
- Outlook next-generation follow-up data analysis (revenue, USD million, 2017 – 2028)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Units
- Other users
- Next Generation Sequencing Data Analysis Regional Forecast (Revenue, USD Million, 2017 – 2028)
- North America
- Europe
- Germany
- RA
- France
- Spain
- Italy
- Russia
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
List of key next generation data analysis (NGS) market players
- Thermo Fisher Scientific, Inc.
- QIAGEN
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- PierianDx
- Bioinformatics Intrexon Germany GmbH
- Tha Partek, Inc.
- Scientific Eurofins
- Pacific Biology California, Inc.
- DNASTAR, Inc.
- Congenica Limited.
- Fabric Genomics, Inc.
- Genuity Science
- DNAnexus Inc.
- SciGenom Labs Pvt. Limited.
- Golden Helix, Inc.
Find more research reports on it Biotechnology industry, by Grand View Research:
- Long Read Sequencing Market – The size of a global running market was appreciated USD 780.0 million in 2018 and is expected to record a CAGR of 23.5% over the expected period.
- DNA Sequencing Market – The market size of a global DNA order was valued USD 4.7 billion in 2019 and is expected to expand at a complex annual growth rate (CAGR) of 11.4% from 2020 to 2027.
- Targeted RNA DNA Classification Market – The global RNA DNA sequencing market size was estimated USD 4.15 billion in 2016. Whole-genome & exome sequence (WGS / WES) offers information about the entire series
Get access to it Grand View Compass, our BI sent an intuitive market research database of 10,000+ reports
About Grand View Search
Grand View Research, a U.S.-based market research and consulting firm, provides research reports in addition to custom research reports and consulting services. Listed in California and headquarters in San Francisco, the company comprises more than 425 analysts and consultants, adding more than 1200 market research reports to its large database each year. These reports offer an analysis of 46 businesses across 25 major countries around the world. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutions understand the global and regional business environment and quantify the opportunities ahead.
Contact:
Sherry James
Corporate sales specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Hole free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Follow us: LinkedIn | Twitter
SOURCE Grand View Research, Inc.
